Concern about the use of venlafaxine to treat vasomotor symptoms

Affiliations

¹ Institute of Basic Medical Sciences, Medical College, Dalian University, Dalian, China.
² Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang, China.

Comment

Shi-Sheng Zhou et al. JAMA Intern Med. 2015 Apr.

. 2015 Apr;175(4):657-8.

doi: 10.1001/jamainternmed.2014.7988.

¹ Institute of Basic Medical Sciences, Medical College, Dalian University, Dalian, China.
² Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang, China.

No abstract available

Comment in

Concern about the use of venlafaxine to treat vasomotor symptoms--reply.
Joffe H, LaCroix AZ, Cohen L. Joffe H, et al. JAMA Intern Med. 2015 Apr;175(4):658-9. doi: 10.1001/jamainternmed.2014.7997. JAMA Intern Med. 2015. PMID: 25844753 No abstract available.

Low-dose estradiol and the serotonin-norepinephrine reuptake inhibitor venlafaxine for vasomotor symptoms: a randomized clinical trial.
Joffe H, Guthrie KA, LaCroix AZ, Reed SD, Ensrud KE, Manson JE, Newton KM, Freeman EW, Anderson GL, Larson JC, Hunt J, Shifren J, Rexrode KM, Caan B, Sternfeld B, Carpenter JS, Cohen L. Joffe H, et al. JAMA Intern Med. 2014 Jul;174(7):1058-66. doi: 10.1001/jamainternmed.2014.1891. JAMA Intern Med. 2014. PMID: 24861828 Free PMC article. Clinical Trial.